UCFA
TGTX icon

United Capital Financial Advisors’s TG Therapeutics TGTX Stock Holding History

United Capital Financial Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-69,010
Closed -$3.33M – 1257
2021
Q1 		$3.33M Buy
69,010
+5
+0% +$240 0.02% 417
2020
Q4 		$3.59M Buy
69,005
+9,140
+15% +$309K 0.02% 406
2020
Q3 		$1.6M Sell
59,865
-245
-0.4% -$5.64K 0.01% 554
2020
Q2 		$1.17M Buy
60,110
+4,750
+9% +$76.5K 0.01% 616
2020
Q1 		$545K Hold
55,360
– – ﹤0.01% 784
2019
Q4 		$614K Sell
55,360
-1,040
-2% -$7.91K ﹤0.01% 933
2019
Q3 		$316K Buy
56,400
+400
+0.7% +$2.79K ﹤0.01% 1063
2019
Q2 		$484K Sell
56,000
-3,000
-5% -$22.7K ﹤0.01% 1062
2019
Q1 		$440K Sell
59,000
-9,100
-13% -$49.2K ﹤0.01% 1019
2018
Q4 		$279K Buy
68,100
+47,000
+223% +$234K ﹤0.01% 1090
2018
Q3 		$118K Sell
21,100
-44,900
-68% -$513K ﹤0.01% 1289
2018
Q2 		$868K Buy
66,000
+16,000
+32% +$220K 0.01% 794
2018
Q1 		$710K Sell
50,000
-16,885
-25% -$216K 0.01% 862
2017
Q4 		$548K Buy
66,885
+8,835
+15% +$77.2K ﹤0.01% 937
2017
Q3 		$688K Hold
58,050
– – 0.01% 874
2017
Q2 		$583K Buy
58,050
+18,000
+45% +$201K 0.01% 892
2017
Q1 		$467K Buy
+40,050
New +$287K ﹤0.01% 924

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

United Capital Financial Advisors's TGTX Position: Q2 2021 in Review

United Capital Financial Advisors sold out of TG Therapeutics (TGTX) in Q2 2021, closing a stake of 69,010 shares — an estimated $3.33M sold.

United Capital Financial Advisors first reported a position in TGTX in Q1 2017 and held it in 17 quarters. The position peaked at $3.59M in Q4 2020. 237 funds tracked by Wall St. Rank hold TGTX as of Q2 2021.

  • United Capital Financial Advisors reported no remaining TG Therapeutics position as of Q2 2021 after selling out during the quarter.
  • United Capital Financial Advisors sold 69,010 TG Therapeutics shares in Q2 2021, an estimated $3.33M.
  • United Capital Financial Advisors first reported a position in TG Therapeutics in Q1 2017 and held it in 17 quarters.
  • United Capital Financial Advisors's TG Therapeutics position peaked at $3.59M in Q4 2020.
  • 237 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2021.

Based on United Capital Financial Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.